American Society of Addiciton Medicine
GuidelinesThe ASAM CriteriaPolicy StatementsDonate
  • Education

    Education

    DEA Education Requirements Addiction Medicine Certification
    eLearning Center
    Live Courses Signature Courses
    Partner Resources
    ASAM Clinical Tips Video Series
  • Quality Care

    Quality Care

    Definition of Addiction
    Clinical Guidelines
    Clinical Recommendations
    The ASAM Criteria
    ASAM CONTINUUM
  • Advocacy

    Advocacy

    Overview National Advocacy
    State Advocacy
    Public Policy Statements
    Educational Policy Briefs Practice Management
    Advocacy in Action
  • Membership

    Membership

    Membership Benefits Membership Types
    State Chapters
    Get Involved
    Online Communities Awards & Scholarships
    Career Center Why I Treat Addiction
  • Publications

    Publications

    Podcasts Textbooks Guidelines The Journal of Addiction Medicine
    The ASAM Weekly
    ASAM Magazine Advertise With ASAM Licensing
    Patient Resources
  • Events

    Events

    ASAM Annual Conference Events
    Upcoming Live Conferences Chapter Events National Addiction Treatment Week
  • News

    News

    Recent News
    Media Relations National Press Resources

Home Publications The ASAM Weekly Detail

  • Home
  • -
  • Publications
  • -
  • The ASAM Weekly
  • -
  • Detail Detail
Detail
  • ASAM Joins Letter Urging Finalization of 2023 Proposed Parity Regulations

    Jun 26, 2024, 13:39 by Molly McGrath
    ASAM joined a letter signed by 40 organizations requesting the Departments of Health and Human Services, Labor, and Treasury finalize the 2023 proposed parity regulations.
    Full story
  • The ASAM Weekly for June 18th, 2024

    Jun 20, 2024, 11:33 by ASAM Weekly Editors
    Piloting a Hospital-Based Rapid Methadone Initiation Protocol for Fentanyl
    Full story
  • The ASAM Weekly for June 11th, 2024

    Jun 20, 2024, 11:31 by ASAM Weekly Editors
    Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
    Full story
  • The ASAM Weekly for June 4th, 2024

    Jun 20, 2024, 11:29 by ASAM Weekly Editors
    Innovation and adaptation: The rise of a fentanyl smoking culture in San Francisco
    Full story
  • ASAM & ACAAM Comment on CMS Rule for GME Fellowships

    Jun 13, 2024, 13:44 by Kelly Corredor
    ASAM & ACAAM Comment on CMS Rule for GME Fellowships
    Full story
  • ASAM Comments on HRSA Reentry Program Guidance

    Jun 13, 2024, 13:29 by Kelly Corredor
    Letter to HRSA on reentry program guidance
    Full story
  • MISAM Comments on Proposal to Expand SUD Health Homes

    Jun 13, 2024, 00:31 by Molly McGrath
    On June 10th, the Michigan Society of Addiction Medicine (MISAM) sent a comment letter to the Michigan Department of Health and Human Services regarding a proposed policy expanding the services provided by Substance Use Disorder (SUD) Health Homes. Specifically, this proposal would add simulant use disorder and alcohol use disorder as eligible diagnoses for reimbursement.
    Full story
  • ASAM Joins Sign-on Letter on Medicare Advantage

    Jun 7, 2024, 14:15 by Kelly Corredor
    Sign-on letter to CMS requests more information and transparency on network adequacy, reimbursement rates and practices, utilization management, cost-sharing, and supplemental benefits.
    Full story
  • In Coalition, ASAM Asks House Appropriations to Uphold Tobacco Fees and Oppose Weakening FDA Authority in Related Bill Markup

    Jun 7, 2024, 14:07 by Molly McGrath
    ASAM signed a letter spearheaded by the Campaign for Tobacco-Free Kids, sent to the leadership of the House Appropriations Committee, urging their approval of the full authorized level of tobacco user fees, and their opposition any efforts to weaken or alter the Food and Drug Administration's authority over tobacco products in the appropriations process.
    Full story
  • FAQs About Medicare Coverage of Injectable Medications

    Jun 6, 2024, 17:46 by Kelly Corredor
    New ASAM resource on Medicare coverage of injectable addiction treatment medications.
    Full story
  • Guest Editorial: How Much Do We Care?

    Jun 3, 2024, 22:29 by Molly McGrath
    The recent article “Has Fentanyl Peaked?” in The New York Times had me asking a different question: How much do we care about Americans with addiction, dying at unprecedented numbers from an increasingly lethal drug supply?
    Full story
  • Stakeholders Ask Administration to Rescind $75 Limit in StimUD Treatment

    May 28, 2024, 16:33 by Molly McGrath
    A group of over fifty stakeholders and leaders called on the Biden Administration to rescind a $75 'cap' per patient per budget year on incentives in contingency management for treating stimulant use disorder (StimUD).
    Full story
  • The ASAM Weekly for May 28th, 2024

    May 28, 2024, 15:02 by ASAM Weekly Editors
    Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
    Full story
  • LASAM Opposes Classifying Mifepristone as a Controlled Substance

    May 22, 2024, 15:14 by Molly McGrath
    On May 17th, Louisiana Society of Addiction Medicine (LASAM) sent a letter of opposition to SB 276 ahead of its consideration by the Louisiana House of Representatives. SB 276 would designate mifepristone as a controlled substance.
    Full story
  • The ASAM Weekly for May 21st, 2024

    May 22, 2024, 08:50 by ASAM Weekly Editors
    Burden of Mental Disorders and Suicide Attributable to Childhood Maltreatment
    Full story
  • LASAM Supports Legislation Raising Medicaid Rates for Physician Services

    May 17, 2024, 07:29 by Molly McGrath
    On May 14th, the Louisiana Society of Addiction Medicine (LASAM) sent a letter supporting SB 190 that would raise Medicaid reimbursement rates for physician services, including substance use disorder (SUD) treatment, to members of the House Committee on Health and Welfare.
    Full story
  • Ten U.S. Senators Circulate Dear Colleague Letter Urging More Funding for the SUD Workforce

    May 15, 2024, 09:08 by Molly McGrath
    The letter asks Congress to fund the SUD Treatment and Recovery Loan Repayment Program (STAR-LRP) at $50 million, and the Addiction Medicine Fellowship (AMF) Program at $30 million, in Fiscal Year 2025.
    Full story
  • COSAM Opposes Prohibiting SSPs in Pueblo

    May 15, 2024, 08:08 by Molly McGrath
    The Colorado Society of Addiction Medicine (COSAM) sent a letter to members of the Pueblo City Council opposing a proposed ordinance banning the operation of syringe service programs (SSPs),
    Full story
  • The ASAM Weekly for May 14th, 2024

    May 14, 2024, 14:52 by ASAM Weekly Editors
    Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior
    Full story
  • Doctors' and Pharmacists' Groups Send Joint Letter to DEA, HHS, ONDCP, and SAMHSA on Buprenorphine Access Issues

    May 10, 2024, 12:37 by Kelly Corredor
    Doctors and Pharmacists groups send letter to federal agencies to highlight buprenorphine access issues in pharmacies and to request clear guidance to ensure patients can get their medications.
    Full story
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10 (current)
  • »

Membership

Join leaders in the field of addiction medicine

Join Today

physician search

Search our physician member directory

Find a physician

newsletter

Receive weekly news and updates from ASAM.

Sign up now

donate

ASAM is a community of hope

Donate Today
ASAM Seal
11400 Rockville Pike, Suite 200, Rockville, MD 20852
301.656.3920

301.656.3815

email@ASAM.org

I would like to...

Become a MemberDonateContact Us

Education

CertificationeLearning CenterLive Courses Host a CourseSignature Courses Fellows, Residents, & Students

Quality Care

Definition of AddictionThe ASAM CriteriaASAM CONTINUUM Clinical Guidelines Publications & Resources

Advocacy

National AdvocacyState Advocacy Public Policy StatementsPractice ManagementAdvocacy in Action Coalitions

Membership

ASAM Connect Membership Benefits Membership TypesState Chapters Get InvolvedAwards & ScholarshipsCareer CenterWhy I Treat Addiction

Publications & Resources

TextbooksGuidelinesThe Journal of Addiction Medicine The ASAM WeeklyAdvertise With ASAMLicensing Patient Resources

Events

Annual ConferenceCE EventsChapter EventsReview Course

News

Recent NewsMedia RelationsNational Press Resources

ASAM Criteria

About the ASAM CriteriaToolkitState ImplementationLevel of Care Certification Training & Consulting ASAM CONTINUUMCopyright & Permissions

About Us

About ASAM2024 ElectionLeadershipASAM StaffCharitable GivingFAQsCareers at ASAMContact Us

More Information

GuidelinesThe ASAM CriteriaPolicy Statement DonateLogin

© 2021 American Society of Addiction Medicine. All rights reserved.

SitemapAdvertisingCopyright and PermissionsTerms of UsePrivacy and Cookie Policies
logo
https://www.asam.org/
American Society of Addiction Medicine is the Nation’s leading addiction medicine society representing physicians, clinicians and other professionals.

Subscribe to Updates

Receive updates from ASAM regarding CME, online education, and events on a variety of addiction-related topics. Subscribe>>>

Subscribe to Updates

Receive the latest news and updates from ASAM's science, health technology, quality care, and publications. Subscribe>>>

Subscribe to Updates

Receive timely and useful news briefings of top stories in addiction policy, combined with ASAM developments related to national and state addiction medicine advocacy. Subscribe>>>

The Time is Now!

Join leaders in the field of addiction medicine. 

Join Today

Subscribe to Updates

Receive the latest news and updates from ASAM's science, health technology, quality care, and publications. Subscribe>>>

Join leaders in the field of addiction medicine

Join Today

Join leaders in the field of addiction medicine

Join Today

Mega menu 2
Mega menu 2
Mega menu 2